RSPO2 and breast carcinoma: Notably, the two cell lines HBcc-15 and BT549 that are derived from breast cancer patients do have EIF3E-RSPO2 gene fusions, and siRNA-mediated inhibition of RSPO2 in BT549 cells was shown to reduce the proliferation of this TNBC cell line [113].